Article
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: data from the DA-COVID-19 registry Running title: AD management during COVID-19 pandemic
2021-01-21
Abstract excerpt
<h4>Background: </h4> Few and small studies have described the management of immunomodulant/immunosuppressive therapies or phototherapy in atopic dermatitis (AD) patients during coronavirus disease 2019 (COVID-19) pandemic. <h4>Methods: </h4>: A national registry, named DA-COVID-19 and involving 35 Italian dermatology units, was established in order to evaluate the impact of COVID-19 pandemic on the management...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- abd87c6c-f1e9-521a-8d7d-a295d4a70857
- DOI
- 10.22541/au.161127068.82018644/v1
